Lyophilized antibiotic-derived cytotoxic agent reconstituted for intravenous or intravesical delivery. Provided by drug manufacturers to surgical and oncology units in medical centers. Purchased by hospital supply chains for application in bladder and gastrointestinal cancer treatments.